Reading Time: 5 minutes Last month we held the 34th International Symposium on ALS/MND in Basel Switzerland. This huge event allows people from across the world to come and find out what research is currently ongoing. Within this 3-day event, we heard from researchers at all stages of their career talk about what projects they have been involved in…
Reading Time: 5 minutes Much like fictional superheroes who are dedicated to protecting the vulnerable with their supernatural abilities, a newly discovered class of ‘Hero’ proteins with unusual properties can prevent toxic protein aggregation seen in several neurodegenerative disorders, such as MND. This finding may have potential for new treatments and applications in biotechnology.
Reading Time: 3 minutes The Science Show on ABC Radio National in Australia, features an interview with Professor Justin Yerbury on Saturday 17th August. The article containing the interview titled ‘Resistant nerves could lead to treatment for neurodegenerative disease‘ is a fascinating insight into Prof Yerbury’s work on the delicate balance of proteins in solution within our nerves and…
Reading Time: 2 minutes In a previous research project funded by the MND Association, Prof Kevin Talbot and colleagues from the University of Oxford developed a new TDP-43 mouse model of MND. Compared to other mouse models of MND, this one accurately reflects the symptoms of the disease and levels of the TDP-43 protein as seen in humans. This…
Reading Time: 3 minutes A few months ago, I attended a media training day. It involved a series of ‘mock’ interviews on radio and TV, performed in studios by experienced journalists. For the first couple of attempts, I was truly awful – it’s so easy to get tied in knots by reporters, especially if they are looking for a…
